These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 15304470
1. Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments. Melese M, Chidambaram JD, Alemayehu W, Lee DC, Yi EH, Cevallos V, Zhou Z, Donnellan C, Saidel M, Whitcher JP, Gaynor BD, Lietman TM. JAMA; 2004 Aug 11; 292(6):721-5. PubMed ID: 15304470 [Abstract] [Full Text] [Related]
5. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions. Biebesheimer JB, House J, Hong KC, Lakew T, Alemayehu W, Zhou Z, Moncada J, Rogér A, Keenan J, Gaynor BD, Schachter J, Lietman TM. Ophthalmology; 2009 Nov 11; 116(11):2047-50. PubMed ID: 19744717 [Abstract] [Full Text] [Related]
6. Trachoma and ocular Chlamydia trachomatis were not eliminated three years after two rounds of mass treatment in a trachoma hyperendemic village. West SK, Munoz B, Mkocha H, Gaydos C, Quinn T. Invest Ophthalmol Vis Sci; 2007 Apr 11; 48(4):1492-7. PubMed ID: 17389476 [Abstract] [Full Text] [Related]
7. A Longitudinal Analysis of Chlamydial Infection and Trachomatous Inflammation Following Mass Azithromycin Distribution. Morberg DP, Alemayehu W, Melese M, Lakew T, Sisay A, Zhou Z, Cevallos V, Oldenburg CE, Porco TC, Lietman TM, Keenan JD. Ophthalmic Epidemiol; 2019 Feb 11; 26(1):19-26. PubMed ID: 30153085 [Abstract] [Full Text] [Related]
11. Comparison of annual versus twice-yearly mass azithromycin treatment for hyperendemic trachoma in Ethiopia: a cluster-randomised trial. Gebre T, Ayele B, Zerihun M, Genet A, Stoller NE, Zhou Z, House JI, Yu SN, Ray KJ, Emerson PM, Keenan JD, Porco TC, Lietman TM, Gaynor BD. Lancet; 2012 Jan 14; 379(9811):143-51. PubMed ID: 22192488 [Abstract] [Full Text] [Related]
16. Frequency of Mass Azithromycin Distribution for Ocular Chlamydia in a Trachoma Endemic Region of Ethiopia: A Cluster Randomized Trial. Lietman TM, Ayele B, Gebre T, Zerihun M, Tadesse Z, Emerson PM, Nash SD, Porco TC, Keenan JD, Oldenburg CE. Am J Ophthalmol; 2020 Jun 25; 214():143-150. PubMed ID: 32171768 [Abstract] [Full Text] [Related]
17. Ribosomal RNA evidence of ocular Chlamydia trachomatis infection following 3 annual mass azithromycin distributions in communities with highly prevalent trachoma. Keenan JD, Ayele B, Gebre T, Moncada J, Stoller NE, Zhou Z, Porco TC, McCulloch CE, Gaynor BD, Emerson PM, Schachter J, Lietman TM. Clin Infect Dis; 2012 Jan 15; 54(2):253-6. PubMed ID: 22095569 [Abstract] [Full Text] [Related]
18. Comparison of Mass Azithromycin Coverage Targets of Children in Niger: A Cluster-Randomized Trachoma Trial. Oldenburg CE, Amza A, Kadri B, Nassirou B, Cotter SY, Stoller NE, West SK, Bailey RL, Porco TC, Gaynor BD, Keenan JD, Lietman TM. Am J Trop Med Hyg; 2018 Feb 15; 98(2):389-395. PubMed ID: 29260659 [Abstract] [Full Text] [Related]
19. Reduction and return of infectious trachoma in severely affected communities in Ethiopia. Lakew T, House J, Hong KC, Yi E, Alemayehu W, Melese M, Zhou Z, Ray K, Chin S, Romero E, Keenan J, Whitcher JP, Gaynor BD, Lietman TM. PLoS Negl Trop Dis; 2009 Feb 15; 3(2):e376. PubMed ID: 19190781 [Abstract] [Full Text] [Related]